Facial rejuvenation is a combination of cosmetic procedures that are used to restore youthful appearance to the human face. Several new and advanced techniques have been introduced in the market to offer non-surgical aesthetics enhancement procedures. Facial rejuvenation is done through surgical procedures such as plastic surgery and also non-invasive or minimally invasive cosmetic treatments such as Botulinum Type- A neurotoxin injections, dermal fillers, chemical peels, and topical applications. The process aims to restore skin elasticity and help maintain youthful appearance in the face and neck region.
Statistics:
The global aesthetics combination therapy market is estimated to account for US$ 4,697.9 Mn in terms of value by the end of 2027.
Global Aesthetics Combination Therapy Market: Drivers
Availability of low-end products in low-income countries is expected to propel growth of the global aesthetics combination therapy market over the forecast period. The penetration of dermatology service providers in low-income countries such as India, Thailand, Malaysia, and Vietnam is high. Dermatologists recommend chemical peels and various creams and lotions as the best treatment options for facial rejuvenation. Moreover, in developed regions, the use of botulinum type-A neurotoxins is high.
Global Aesthetics Combination Therapy Market: Opportunities
Majority of patients worldwide prefer botulinum neurotoxin type-A for reducing wrinkles in the upper-third portion of the face (triangle region). However, currently there are few major suppliers of botulinum products, which leads to preferential pricing of the product. Therefore, increasing manufacturing output of botulinum products and emergence of new players focused on botulinum productions is expected to aid in growth of the market.
Global Aesthetics Combination Therapy Market: Restraints
Improper training to professionals could result in serious complications, thereby hampering growth of the market. Treatments are sometimes not administered properly, which results in severe or adverse side effects. Fillers are injected around the temple region to reduce crow’s feet and even out fine lines. Patients may experience symptoms such as flu, fever, extreme pain, and swelling within 48 hours, if the injection punctures a facial vein while being administered. Such accidents would prompt administering of steroids and antibiotics to patients.
Moreover, high procedure fees limits repeat visits of customers, especially in emerging economies. Dermatologists may charge around US$ 2,100 for a single ablative laser procedure. Other aesthetic combination procedures or treatments could carry a price tag, which is over 50% more compared to normal facial or beauty treatments. Moreover, several emerging economies do not offer reimbursements for minimally invasive treatments and procedures, which further hinders growth of the market.
Key Takeaways:
The BTx-A/Dermal Filler segment in the global aesthetics combination therapy market was valued at US$ 727.2 Mn in 2019 and is expected to reach US$ 1,713.1 Mn by 2027 at a CAGR of 11.3% during the forecast period. The growth of the segment is attributed to increasing demand for facial aesthetic procedures for skin tightening in developed and developing economies during the forecast period.
The scar removal segment held dominant position in the global aesthetics combination therapy market in 2019, accounting for 28.6% share in terms of value, followed by skin resurfacing, respectively. Increasing disposable income in developing economies of Asia Pacific along with growing demand for aesthetic procedures is expected to assist the growth of the segment during the forecast period.
Market Trends
The adoption of fillers such as hyaluronic acid, polylactic acid, or hydroxylapatite is high following botox treatments in women between 35 and 55. Moreover, office-based non-invasive and minimally invasive procedures are gaining popularity among lower age groups aged between 25 and 30 years and 31-35 years.
The demand for beauty treatment is growing among men in East Asia. For instance, according to a 2018 survey by GlobalData, around three quarters of South Korean men undertake a beauty or grooming treatment at least once a week.
Global Aesthetics Combination Therapy Market: Competitive Landscape
Major players operating in the global aesthetics combination therapy market include, Alma Lasers, Lumenis Ltd., Cynosure Inc., Bausch Health Companies Inc., Galderma S.A., Anika Therapeutics, Inc., Speciality European Pharma, Merz Pharma GmbH & Co. KGaA, Cutera, Inc., Syneron Medical Ltd., and Allergan.
Aesthetics Combination Therapy Market: Key Developments
- January 2020: Allergan plc launched SkinMedica Instant Bright Eye Cream, an eye treatment that hydrates, brightens and helps visibly firm the appearance of the delicate skin around the eyes
- April 2019: Lumenis Ltd. launched its newest platform, the Legend Pro+, a multi-application platform that uses a combination of TriPollar RF energy and DMA Muscle energy for the treatment of the skin, toning the muscles of the face, and the body through the epidermal layer
Segmentation
- Aesthetic Combination Therapy Market, By Therapy Type:
- BTx-A/Dermal Filler
- BTx-A/Laser
- Laser/Topical Drug
- Laser/Radiofrequency
- Dermal Filler/Topical Drug
- Others
- Aesthetic Combination Therapy Market, By Application:
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Scar Removal
- Others
- Aesthetic Combination Therapy Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- Aesthetic Combination Therapy Market, By Region:
- North America
- By Therapy Type:
- BTx-A/Dermal Filler
- BTx-A/Laser
- Laser/Topical Drug
- Laser/Radiofrequency
- Dermal Filler/Topical Drug
- Others
- By Application
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Scar Removal
- Others
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- By Country:
- U.S.
- Canada
- Latin America
- By Therapy Type:
- BTx-A/Dermal Filler
- BTx-A/Laser
- Laser/Topical Drug
- Laser/Radiofrequency
- Dermal Filler/Topical Drug
- Others
- By Application
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Scar Removal
- Others
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Therapy Type:
- BTx-A/Dermal Filler
- BTx-A/Laser
- Laser/Topical Drug
- Laser/Radiofrequency
- Dermal Filler/Topical Drug
- Others
- By Application
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Scar Removal
- Others
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Therapy Type:
- BTx-A/Dermal Filler
- BTx-A/Laser
- Laser/Topical Drug
- Laser/Radiofrequency
- Dermal Filler/Topical Drug
- Others
- By Application
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Scar Removal
- Others
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Therapy Type:
- BTx-A/Dermal Filler
- BTx-A/Laser
- Laser/Topical Drug
- Laser/Radiofrequency
- Dermal Filler/Topical Drug
- Others
- By Application
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Scar Removal
- Others
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Therapy Type:
- BTx-A/Dermal Filler
- BTx-A/Laser
- Laser/Topical Drug
- Laser/Radiofrequency
- Dermal Filler/Topical Drug
- Others
- By Application
- Hair Removal
- Tattoo Removal
- Skin Resurfacing
- Scar Removal
- Others
- By End User
- Hospitals
- Ambulatory Surgical Centers
- Dermatology Clinics
- By Country:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Alma Lasers *
- Company Overview
- Product Portfolio
- Key Highlights
- Financial Overview
- Strategies
- Lumenis Ltd.
- Cynosure Inc.
- Bausch Health Companies Inc.
- Galderma S.A
- Anika Therapeutics Inc.
- Speciality European Pharma
- Merz Pharma GmbH & Co. KGaA
- Cutera, Inc.
- Syneron Medical Ltd.
- Allergan
- “*” marked represents similar segmentation in other categories in the respective section.
